Financhill
Back

Tango Therapeutics Stock Predictions

Tango Therapeutics Stock Forecast

  • Is Tango Therapeutics Stock Undervalued?
    The current Tango Therapeutics [TNGX] share price is $3.56. The Score for TNGX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • TNGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Tango Therapeutics Stock Go Up Next Year?

Data Unavailable

Tango Therapeutics Stock Rating

Data Unavailable

Tango Therapeutics Stock Price History

Is TNGX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNGX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tangotx.com

52-Week Data

52-Week High:
13.01
52-Week Low:
2.70

Prediction Charts

Market Cap:
382.41M
Price in USD:
3.56
Volume:
2.81M
Beta:
0.87

Technical Analysis

SMA50:
7.02
SMA100:
8.37
SMA200:
8.64
52-Wk Change:
-52.97%

Stock Predictions

  • Is Tango Therapeutics stock public?
    Yes, Tango Therapeutics is a publicly traded company.
  • What is the Tango Therapeutics stock quote today?
    The Tango Therapeutics stock price is 3.56 USD today.
  • How to buy Tango Therapeutics stock online?
    You can buy Tango Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 6.31 5.93 6.98 5.83
Oct-28 5.97 5.92 6.15 5.83
Oct-29 5.89 6.00 6.02 5.62
Oct-30 5.99 5.72 6.00 5.69
Oct-31 5.64 5.44 5.69 5.43
Nov-1 5.42 5.15 5.47 5.07
Nov-4 5.12 5.16 5.30 5.07
Nov-5 5.11 5.18 5.21 4.93
Nov-6 3.05 3.22 3.94 2.91
Nov-7 3.30 2.83 3.71 2.77
Nov-8 2.90 2.95 3.03 2.71
Nov-11 2.92 3.38 3.41 2.70
Nov-12 3.48 3.35 3.60 3.26
Nov-13 3.37 3.56 3.80 3.31

Tango Therapeutics Earnings

Data Unavailable

Tango Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and a decrease next year of $0.24 per share.

* Tango Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.